Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Osteoarthritis 1Low Back Pain 1Cancer Pain 1

Interventions

Oxycodone 5Morphine 5nabiximols 4Naloxone 2Fentanyl 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1naloxegol 1incobotulinumtoxinA 1Water 1Transcranial Direct Current Stimulation 1Tapentadol 1Sodium Bicarbonate 1Methadone 1Lidocaine 1Lenalidomide 1Ketamine 1Inosine Monophosphate 1Hydromorphone 1Glucose 1Donepezil 1Cognitive Behavioral Therapy 1Buprenorphine 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Cancer Pain × Inosine Monophosphate × Clear all
NCT03031938 2021-06-25

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Pfizer

Phase 3 Completed
4 enrolled 78 charts

Cancer Pain, Osteoarthritis, Low Back Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡